
Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. Centers for Medicare and Medicaid Services (CMS) tend to cover with little fanfare… read on > read on >